{"title":"口服沙丁胺醇治疗幼儿哮喘。","authors":"M T Lin, C Collins-Williams","doi":"10.3109/02770907709104342","DOIUrl":null,"url":null,"abstract":"<p><p>Twenty-one young asthmatics, 2-6 years of age (mean 4 years), were given an open trial of salbutamol syrup to assess its safety. Each patient was given 1 mg, then 2 mg, q8h for two weeks. Only one patient experienced side-effects and this was at the 2 mg dose. It is concluded that salbutamol syrup is safe at a dose of 1 to 2 mg q8h for the asthmatic children in this age group.</p>","PeriodicalId":76644,"journal":{"name":"The Journal of asthma research","volume":"15 1","pages":"1-3"},"PeriodicalIF":0.0000,"publicationDate":"1977-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/02770907709104342","citationCount":"1","resultStr":"{\"title\":\"Oral salbutamol therapy of asthma in young children.\",\"authors\":\"M T Lin, C Collins-Williams\",\"doi\":\"10.3109/02770907709104342\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Twenty-one young asthmatics, 2-6 years of age (mean 4 years), were given an open trial of salbutamol syrup to assess its safety. Each patient was given 1 mg, then 2 mg, q8h for two weeks. Only one patient experienced side-effects and this was at the 2 mg dose. It is concluded that salbutamol syrup is safe at a dose of 1 to 2 mg q8h for the asthmatic children in this age group.</p>\",\"PeriodicalId\":76644,\"journal\":{\"name\":\"The Journal of asthma research\",\"volume\":\"15 1\",\"pages\":\"1-3\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1977-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.3109/02770907709104342\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Journal of asthma research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3109/02770907709104342\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of asthma research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3109/02770907709104342","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Oral salbutamol therapy of asthma in young children.
Twenty-one young asthmatics, 2-6 years of age (mean 4 years), were given an open trial of salbutamol syrup to assess its safety. Each patient was given 1 mg, then 2 mg, q8h for two weeks. Only one patient experienced side-effects and this was at the 2 mg dose. It is concluded that salbutamol syrup is safe at a dose of 1 to 2 mg q8h for the asthmatic children in this age group.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
